{"id":"triptorelin-for-injection","safety":{"commonSideEffects":[{"rate":"50-80%","effect":"Hot flashes"},{"rate":"20-50%","effect":"Nausea"},{"rate":"10-30%","effect":"Headache"},{"rate":"10-30%","effect":"Injection site reaction"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By binding to GnRH receptors in the pituitary gland, triptorelin triggers a cascade of downstream effects that ultimately lead to the suppression of gonadotropin secretion, resulting in decreased levels of sex hormones such as testosterone and estrogen.","oneSentence":"Triptorelin for Injection is a synthetic decapeptide analogue of gonadotropin-releasing hormone (GnRH) that acts as a potent agonist.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:40:12.258Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prostate cancer"},{"name":"Premature puberty"}]},"trialDetails":[{"nctId":"NCT04484818","phase":"PHASE3","title":"Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2021-03-01","conditions":"Prostate Carcinoma","enrollment":27},{"nctId":"NCT06282588","phase":"PHASE2, PHASE3","title":"Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers","status":"RECRUITING","sponsor":"Cancer Research Antwerp","startDate":"2023-12-13","conditions":"Prostate Cancer","enrollment":493},{"nctId":"NCT07319429","phase":"PHASE2, PHASE3","title":"Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification","status":"RECRUITING","sponsor":"Fudan University","startDate":"2026-01-25","conditions":"Endometrial Cancer, Fertility","enrollment":260},{"nctId":"NCT07142551","phase":"PHASE2","title":"Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response","status":"RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2026-03-09","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":60},{"nctId":"NCT04931342","phase":"PHASE2","title":"A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2021-10-07","conditions":"Ovarian Cancer","enrollment":176},{"nctId":"NCT07455903","phase":"PHASE2","title":"Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT","status":"NOT_YET_RECRUITING","sponsor":"Baptist Health South Florida","startDate":"2026-04","conditions":"Prostate Cancer, Localized Prostate Carcinoma","enrollment":50},{"nctId":"NCT06134479","phase":"PHASE3","title":"Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation.","status":"COMPLETED","sponsor":"Fundación Santiago Dexeus Font","startDate":"2023-12-12","conditions":"Fertility","enrollment":194},{"nctId":"NCT03332797","phase":"PHASE1","title":"A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Genentech, Inc.","startDate":"2017-11-24","conditions":"Breast Cancer","enrollment":181},{"nctId":"NCT00066703","phase":"PHASE3","title":"Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer","status":"COMPLETED","sponsor":"ETOP IBCSG Partners Foundation","startDate":"2003-11-03","conditions":"Breast Cancer","enrollment":2672},{"nctId":"NCT00066690","phase":"PHASE3","title":"Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer","status":"COMPLETED","sponsor":"ETOP IBCSG Partners Foundation","startDate":"2003-12-17","conditions":"Estrogen Receptor Positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Carcinoma","enrollment":3066},{"nctId":"NCT04356664","phase":"PHASE2, PHASE3","title":"Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis","status":"RECRUITING","sponsor":"Hopital Foch","startDate":"2021-03-18","conditions":"Endometriosis, Adenomyosis, Infertility, Female","enrollment":180},{"nctId":"NCT07340619","phase":"PHASE2","title":"Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.","status":"NOT_YET_RECRUITING","sponsor":"UNICANCER","startDate":"2026-05-18","conditions":"Metastatic (Stage IV) Melanoma","enrollment":51},{"nctId":"NCT05746806","phase":"NA","title":"Trial of Ultrahypofractionated Focal Salvage Radiotherapy for Isolated Prostate Bed Recurrence After Radical Prostatectomy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2023-03-29","conditions":"Recurrent Prostate Cancer","enrollment":36},{"nctId":"NCT06528210","phase":"PHASE2","title":"Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer","status":"WITHDRAWN","sponsor":"OHSU Knight Cancer Institute","startDate":"2025-04-16","conditions":"High Risk Prostate Carcinoma, Localized Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8","enrollment":""},{"nctId":"NCT03678025","phase":"PHASE3","title":"Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer","status":"RECRUITING","sponsor":"SWOG Cancer Research Network","startDate":"2018-09-24","conditions":"Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8","enrollment":1273},{"nctId":"NCT05458856","phase":"PHASE3","title":"Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate","status":"COMPLETED","sponsor":"Ipsen","startDate":"2022-08-30","conditions":"Prostate Cancer","enrollment":147},{"nctId":"NCT07076719","phase":"","title":"Cell-free DNA Analysis of Spent Embryo Culture Media as a Non-invasive Approach for Preimplantation Genetic Diagnosis","status":"COMPLETED","sponsor":"Sohag University","startDate":"2023-10-01","conditions":"to Evaluate the Feasibility and Accuracy of Using cfDNA Analysis of Spent Embryo Culture Media as a Non-invasive Approach for PGD","enrollment":20},{"nctId":"NCT01673984","phase":"PHASE4","title":"GP Extended Action Triptorelin","status":"TERMINATED","sponsor":"Ipsen","startDate":"2012-08","conditions":"Prostate Cancer","enrollment":27},{"nctId":"NCT05982093","phase":"PHASE2","title":"Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"SOLTI Breast Cancer Research Group","startDate":"2023-02-03","conditions":"Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Tumor","enrollment":48},{"nctId":"NCT00567580","phase":"PHASE3","title":"Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Radiation Therapy Oncology Group","startDate":"2008-02","conditions":"Prostate Cancer","enrollment":1792},{"nctId":"NCT06225284","phase":"PHASE2","title":"Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2024-08-22","conditions":"Triple Negative Breast Cancer, Premenopausal Breast Cancer","enrollment":124},{"nctId":"NCT05029622","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants With Central Precocious Puberty.","status":"COMPLETED","sponsor":"Ipsen","startDate":"2021-08-10","conditions":"Central Precocious Puberty","enrollment":66},{"nctId":"NCT05286554","phase":"PHASE4","title":"Addition of Gonadotropin Releasing Hormone Agonist to Luteal Phase Support","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2022-03-17","conditions":"Female Infertility","enrollment":75},{"nctId":"NCT04992026","phase":"PHASE2","title":"The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer","status":"COMPLETED","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2021-01-01","conditions":"Prostatectomy, Oligometastatic Prostate Cancer, Abiraterone","enrollment":130},{"nctId":"NCT02685397","phase":"PHASE2, PHASE3","title":"Management of Castration-Resistant Prostate Cancer with Oligometastases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sir Mortimer B. Davis - Jewish General Hospital","startDate":"2016-10","conditions":"Castration-resistant Prostate Cancer Patients with Oligometastases","enrollment":102},{"nctId":"NCT00702520","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-04-01","conditions":"Pregnancy, Neonates","enrollment":15},{"nctId":"NCT06581679","phase":"NA","title":"Adenomyosis and Pregnancy: Levonorgestrel vs. GnRH for Blastocyst Transfer","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2023-12-15","conditions":"Adenomyosis","enrollment":184},{"nctId":"NCT04736602","phase":"PHASE3","title":"Efficacy and Safety Study of Triptorelin 3-Month Formulation in Chinese Children With Central Precocious Puberty.","status":"COMPLETED","sponsor":"Ipsen","startDate":"2021-03-27","conditions":"Central Precocious Puberty","enrollment":32},{"nctId":"NCT06481696","phase":"NA","title":"Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility","status":"RECRUITING","sponsor":"Andros Day Surgery Clinic","startDate":"2024-06-01","conditions":"Unexplained Infertility","enrollment":90},{"nctId":"NCT02418572","phase":"PHASE3","title":"Testosterone TRANSdermal Gel for Poor Ovarian Responders Trial","status":"TERMINATED","sponsor":"Fundacion Dexeus","startDate":"2015-04","conditions":"Infertility, Poor Ovarian Response","enrollment":290},{"nctId":"NCT05802303","phase":"NA","title":"Estrogen (Gel)Transdermal vs Oral Estrogen for Endometrial Preparation","status":"TERMINATED","sponsor":"Indira IVF Hospital Pvt Ltd","startDate":"2023-07-25","conditions":"Frozen Embryo Transfer, Infertility, Female","enrollment":172},{"nctId":"NCT03899077","phase":"PHASE2","title":"Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP","status":"UNKNOWN","sponsor":"Cancer Research Antwerp","startDate":"2019-04-05","conditions":"Cancer of Prostate","enrollment":202},{"nctId":"NCT05851547","phase":"PHASE2","title":"Dose Escalation For INtraprostatic LEsions","status":"RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2023-11-23","conditions":"Prostatic Neoplasms","enrollment":54},{"nctId":"NCT05567731","phase":"NA","title":"Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-10-15","conditions":"Intracytoplasmic Sperm Injection, GnRH Agonist, Infertility","enrollment":30},{"nctId":"NCT05781217","phase":"PHASE3","title":"Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624","status":"RECRUITING","sponsor":"Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic","startDate":"2023-03-14","conditions":"Prostate Cancer, Salvage Radiotherapy, Biochemical Recurrence","enrollment":534},{"nctId":"NCT05328258","phase":"PHASE3","title":"Use of GnRHa During Chemotherapy for Fertility Protection","status":"RECRUITING","sponsor":"Kenny Rodriguez-Wallberg","startDate":"2023-03-31","conditions":"Breast Cancer Female, Acute Leukemia, Lymphoma","enrollment":500},{"nctId":"NCT05555017","phase":"PHASE2","title":"Tracer-Guided Surgery for Recurrent Prostate Cancer","status":"UNKNOWN","sponsor":"The Netherlands Cancer Institute","startDate":"2023-02-15","conditions":"Prostate Cancer","enrollment":60},{"nctId":"NCT05972902","phase":"PHASE3","title":"Dydrogesterone, Cetrorelix Acetate and Triptorelin in Intra Cytoplasmic Sperm Injection Outcomes","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-07-15","conditions":"IVF","enrollment":387},{"nctId":"NCT05945407","phase":"NA","title":"Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer","status":"RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2016-08-01","conditions":"Endometrial Neoplasms, Endometrial Neoplasm Malignant, Endometrial Neoplasm Malignant Stage I","enrollment":57},{"nctId":"NCT04616729","phase":"PHASE1, PHASE2","title":"DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2022-11-01","conditions":"Breast Cancer Female","enrollment":30},{"nctId":"NCT04071574","phase":"PHASE1, PHASE2","title":"Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility","status":"COMPLETED","sponsor":"Lebanese University","startDate":"2018-02-01","conditions":"Female Infertility, Female Infertility Due to Ovulatory Disorder, Premature Ovarian Failure","enrollment":200},{"nctId":"NCT04869371","phase":"PHASE2","title":"Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer","status":"UNKNOWN","sponsor":"Hongqian Guo","startDate":"2018-12-12","conditions":"Neoadjuvant Therapy \\ High Risk Prostate Cancer \\ Docetaxel","enrollment":75},{"nctId":"NCT02113553","phase":"PHASE2","title":"Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve","status":"TERMINATED","sponsor":"Armando Santoro, MD","startDate":"2013-05","conditions":"Breast Cancer","enrollment":45},{"nctId":"NCT05397795","phase":"PHASE3","title":"COMPARING TWO PROTOCOLS FOR FINAL OOCYTE MATURATION IN POOR RESPONDERS UNDERGOING GnRH-ANTAGONIST ICSI CYCLES","status":"UNKNOWN","sponsor":"Alexandria University","startDate":"2022-06-01","conditions":"Infertility","enrollment":160},{"nctId":"NCT05212857","phase":"PHASE2","title":"Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer","status":"UNKNOWN","sponsor":"Fudan University","startDate":"2022-04","conditions":"Prostate Cancer","enrollment":160},{"nctId":"NCT04537078","phase":"PHASE3","title":"Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders","status":"COMPLETED","sponsor":"El Shatby University Hospital for Obstetrics and Gynecology","startDate":"2020-09-01","conditions":"Infertility, Female","enrollment":90},{"nctId":"NCT00725491","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-05","conditions":"Controlled Ovarian Stimulation","enrollment":259},{"nctId":"NCT05151016","phase":"EARLY_PHASE1","title":"Long-term Use of Mifepristone in the Treatment of Adenomyosis","status":"UNKNOWN","sponsor":"Women's Hospital School Of Medicine Zhejiang University","startDate":"2021-12-01","conditions":"Adenomyosis, Mifepristone","enrollment":140},{"nctId":"NCT05112692","phase":"NA","title":"Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2021-11","conditions":"PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries","enrollment":200},{"nctId":"NCT04854707","phase":"","title":"An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data","status":"COMPLETED","sponsor":"IVFarma LLC","startDate":"2020-01-12","conditions":"Reproductive Issues, Reproductive Disorder, Fertility Disorders","enrollment":5484},{"nctId":"NCT03232281","phase":"PHASE3","title":"Study to Compare the Oestradiol Suppression, Clinical Efficacy and Safety of Two Formulations of Triptorelin (Triptorelin Pamoate PR 3-month and Triptorelin Acetate PR 1-month) in Chinese Subjects With Endometriosis","status":"COMPLETED","sponsor":"Ipsen","startDate":"2017-07-28","conditions":"Endometriosis","enrollment":300},{"nctId":"NCT04717752","phase":"NA","title":"A Randomized Controlled Study of Different Trigger Modes of Antagonist Regimen in Patients With Low Ovarian Reserve","status":"UNKNOWN","sponsor":"Nanjing University","startDate":"2021-01-20","conditions":"Poor Ovarian Response","enrollment":310},{"nctId":"NCT00090844","phase":"PHASE2","title":"Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer","status":"TERMINATED","sponsor":"University of South Florida","startDate":"2004-07","conditions":"Breast Cancer, Hormone Changes, Drug Toxicity","enrollment":49},{"nctId":"NCT03536234","phase":"PHASE2","title":"Efficacy and Safety of GnRH Analogue Triptorelin for HIV-1 Reservoir Reduction in ART Treated HIV-1 Infected Patients","status":"UNKNOWN","sponsor":"Immune System Regulation AB","startDate":"2018-09-19","conditions":"HIV-1-infection","enrollment":52},{"nctId":"NCT00124514","phase":"PHASE2","title":"Triptorelin for Ovary Protection in Childhood Onset Lupus","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2003-06","conditions":"Systemic Lupus Erythematosus","enrollment":31},{"nctId":"NCT03291821","phase":"NA","title":"DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore","status":"COMPLETED","sponsor":"IVI Madrid","startDate":"2017-12-01","conditions":"Infertility, Female","enrollment":136},{"nctId":"NCT01753297","phase":"PHASE4","title":"A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.","status":"COMPLETED","sponsor":"Ipsen","startDate":"2012-12-11","conditions":"Prostate Cancer","enrollment":226},{"nctId":"NCT03428919","phase":"NA","title":"ICSI Versus Conventional IVF in Non-male Factor Couples","status":"COMPLETED","sponsor":"Mỹ Đức Hospital","startDate":"2018-03-16","conditions":"Infertility","enrollment":1064},{"nctId":"NCT03115307","phase":"PHASE4","title":"Luteal Phase Support in Insemination Cycles","status":"COMPLETED","sponsor":"Tampere University Hospital","startDate":"2017-01","conditions":"Infertility, Female","enrollment":167},{"nctId":"NCT02856048","phase":"PHASE2, PHASE3","title":"Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-11-23","conditions":"Cancer, Toxicity Due to Chemotherapy, Sarcoma","enrollment":11},{"nctId":"NCT01313273","phase":"PHASE3","title":"Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients","status":"TERMINATED","sponsor":"Ipsen","startDate":"2011-06","conditions":"Prostate Cancer","enrollment":3},{"nctId":"NCT04008966","phase":"PHASE4","title":"Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles","status":"COMPLETED","sponsor":"Cairo University","startDate":"2016-07-20","conditions":"Assisted Reproduction","enrollment":160},{"nctId":"NCT02005887","phase":"PHASE2","title":"TRial on the Endocrine Activity of Neoadjuvant Degarelix","status":"COMPLETED","sponsor":"ETOP IBCSG Partners Foundation","startDate":"2014-02","conditions":"Breast Cancer Invasive Nos","enrollment":51},{"nctId":"NCT03954197","phase":"NA","title":"Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients","status":"UNKNOWN","sponsor":"Hôpital Jean Verdier","startDate":"2014-09-09","conditions":"Fertility Preservation, Breast Cancer","enrollment":204},{"nctId":"NCT03809221","phase":"PHASE4","title":"The Effectiveness and Safety of the Prolonged Down-regulation Protocol for Controlled Ovarian Hyperstimulation","status":"UNKNOWN","sponsor":"Peking University People's Hospital","startDate":"2019-02-01","conditions":"Infertility, Female","enrollment":1892},{"nctId":"NCT03784404","phase":"PHASE4","title":"Trans-vaginal Aspiration of Small Ovarian Endometrioma. Comparison of Two Different Techniques Before ICSI","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2018-12","conditions":"Ovarian Endometrioma","enrollment":100},{"nctId":"NCT01942369","phase":"","title":"A Study to Describe the Efficacy of Diphereline Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months","status":"COMPLETED","sponsor":"Ipsen","startDate":"2013-09-16","conditions":"Deep Infiltrating Endometriosis (DIE)","enrollment":402},{"nctId":"NCT02715232","phase":"PHASE4","title":"Effects of Sex Steroids on the Serotonin System","status":"UNKNOWN","sponsor":"Medical University of Vienna","startDate":"2017-02-06","conditions":"Gender Dysphoria","enrollment":92},{"nctId":"NCT03684824","phase":"NA","title":"Accuracy of Ultrasound Markers Versus Biochemical Markers in Prediction of Ovarian Response in Obese Women Undergoing IVF/ICSI Treatment","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2018-09","conditions":"Invitro Fertilization","enrollment":100},{"nctId":"NCT03397537","phase":"PHASE2","title":"Neoadjuvant Endocrine Therapy in Breast Cancer","status":"COMPLETED","sponsor":"Guangdong Provincial People's Hospital","startDate":"2012-09","conditions":"Highly Endocrine Responsive Operable Breast Cancer","enrollment":46},{"nctId":"NCT02381821","phase":"","title":"Endometrial Volume and Sub-endometrial Vascularity as Predictors of In-vitro Fertilization Success","status":"COMPLETED","sponsor":"Cairo University","startDate":"2016-01-01","conditions":"Reproductive Techniques, Assisted","enrollment":82},{"nctId":"NCT02741154","phase":"PHASE4","title":"Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of ICSI","status":"COMPLETED","sponsor":"Minia University","startDate":"2016-08-12","conditions":"Infertility Indicated for ICSI","enrollment":50},{"nctId":"NCT01467882","phase":"PHASE3","title":"Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty","status":"COMPLETED","sponsor":"Debiopharm International SA","startDate":"2012-04","conditions":"Central Precocious Puberty","enrollment":44},{"nctId":"NCT03139474","phase":"PHASE2, PHASE3","title":"Impact of Gonadotrophin Releasing Hormone Analogues on Oocyte and Embryo Quality","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2017-06-01","conditions":"Infertility, Female","enrollment":120},{"nctId":"NCT02732808","phase":"PHASE3","title":"Dual Ovarian Stimulation in the Same IVF/ICSI Cycles for Treatment of Poor Ovarian Responders","status":"COMPLETED","sponsor":"Royan Institute","startDate":"2014-09","conditions":"Infertility","enrollment":50},{"nctId":"NCT03005275","phase":"NA","title":"A Comparison of Cost - Effectiveness of Stimulated ICSI and IVM Strategy in PCOS Women","status":"WITHDRAWN","sponsor":"Vietnam National University","startDate":"2017-01","conditions":"Infertility","enrollment":""},{"nctId":"NCT03071172","phase":"PHASE3","title":"Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET","status":"UNKNOWN","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2017-03","conditions":"Ovarian Hyperstimulation Syndrome","enrollment":252},{"nctId":"NCT02208986","phase":"NA","title":"GnRHa Trigger in Asian Oocyte Donors- a Dose Finding Study","status":"COMPLETED","sponsor":"Vietnam National University","startDate":"2014-08","conditions":"Normal Oocyte Donors","enrollment":165},{"nctId":"NCT00066807","phase":"PHASE3","title":"Premenopausal Endocrine Responsive Chemotherapy Trial","status":"TERMINATED","sponsor":"ETOP IBCSG Partners Foundation","startDate":"2003-08","conditions":"Breast Cancer","enrollment":29},{"nctId":"NCT00659373","phase":"PHASE3","title":"Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02","status":"COMPLETED","sponsor":"ETOP IBCSG Partners Foundation","startDate":"2007-12","conditions":"Breast Cancer, Fatigue, Sleep Disorders","enrollment":86},{"nctId":"NCT01590173","phase":"PHASE2, PHASE3","title":"Addition of Prednisolone and Heparin in Patients Undergoing IVF With Failed IVF Cycles","status":"COMPLETED","sponsor":"National and Kapodistrian University of Athens","startDate":"2012-01","conditions":"Infertility","enrollment":86},{"nctId":"NCT01979341","phase":"NA","title":"The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes","status":"WITHDRAWN","sponsor":"Antalya IVF","startDate":"2013-10","conditions":"Pregnancy, Ovarian Hyperstimulation Syndrome","enrollment":""},{"nctId":"NCT02635607","phase":"NA","title":"Effectiveness and Safety Study of Fixed Versus Flexible of Gonadotropin-releasing Hormone Antagonist Protocol","status":"UNKNOWN","sponsor":"Chong Qing Reproducive and Genetic Institute","startDate":"2016-01","conditions":"Infertility","enrollment":200},{"nctId":"NCT02201914","phase":"PHASE4","title":"Clomiphene Citrate Plus Gonadotropins and GnRH Antagonist Versus Flexible GnRH Antagonist Protocol Versus Microdose GnRH Agonist Protocol in Poor Responders Undergoing IVF","status":"UNKNOWN","sponsor":"Bioroma","startDate":"2014-01","conditions":"Poor Responders, IVF, Clomiphene Citrate","enrollment":250},{"nctId":"NCT02022241","phase":"NA","title":"Repeated Injection of GnRH Agonist to Reduce Ovarian Hyperstimulation Syndrome","status":"UNKNOWN","sponsor":"Chenshiling","startDate":"2012-07","conditions":"Infertility and at High Risk of OHSS","enrollment":80},{"nctId":"NCT01161563","phase":"PHASE4","title":"Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration","status":"COMPLETED","sponsor":"Watson Pharmaceuticals","startDate":"2010-07","conditions":"Prostate Cancer","enrollment":118},{"nctId":"NCT00764166","phase":"PHASE3","title":"A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-Docetaxel","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2003-06","conditions":"Adenocarcinoma of the Prostate","enrollment":254}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Gonadotropin releasing hormone agonists"],"phase":"phase_3","status":"active","brandName":"Triptorelin for Injection","genericName":"Triptorelin for Injection","companyName":"Changchun GeneScience Pharmaceutical Co., Ltd.","companyId":"changchun-genescience-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Triptorelin for Injection is a synthetic decapeptide analogue of gonadotropin-releasing hormone (GnRH) that acts as a potent agonist. Used for Prostate cancer, Premature puberty.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}